Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor

Details for Australian Patent Application No. 2005270314 (hide)

Owner Novartis AG

Inventors Bloomfield, Graham Charles; McCarthy, Clive; Leblanc, Catherine; Press, Neil John

Agent Davies Collison Cave

Pub. Number AU-B-2005270314

PCT Pub. Number WO2006/015860

Priority 0417910.7 11.08.04 GB

Filing date 10 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 30 April 2009

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015860 Priority application(s): WO2006/015860

30 April 2009 Application Accepted

  Published as AU-B-2005270314

27 August 2009 Standard Patent Sealed

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270319-Fungicidal compositions

2005270313-Trifluoromethyl substituted benzamides as kinase inhibitors